Cardiac protection by the cyclin-dependent kinase (Cdk) inhibitor p21 is a function of the endogenous protein, unrelated to inhibition of Cdk activity

被引:0
|
作者
Wang, XZ [1 ]
Zhan, S [1 ]
Schneider, MD [1 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
684
引用
收藏
页码:142 / 142
页数:1
相关论文
共 50 条
  • [21] Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-Cdk2 and cyclin D2-Cdk4
    Blain, SW
    Montalvo, E
    Massague, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) : 25863 - 25872
  • [22] PKC REGULATION OF THE CYCLIN DEPENDENT KINASE (CDK) INHIBITOR P21 IN NORMAL KIDNEY VERSUS KIDNEY CANCER CELLS
    Li, J.
    Gobe, G. C.
    NEPHROLOGY, 2006, 11 : A42 - A42
  • [23] Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein
    Dimri, GP
    Nakanishi, M
    Desprez, PY
    Smith, JR
    Campisi, J
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (06) : 2987 - 2997
  • [24] Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein
    Johannessen, LE
    Knardal, SL
    Madshus, IH
    BIOCHEMICAL JOURNAL, 1999, 337 : 599 - 606
  • [25] PERTURBATION OF A CIRCADIAN CLOCK BY THE SPECIFIC CYCLIN-DEPENDENT KINASE (CDK) INHIBITOR, OLOMOUCINE
    KRUCHER, NA
    ROBERTS, MH
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 2054 - 2054
  • [26] The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress
    O'Reilly, MA
    Staversky, RJ
    Watkins, RH
    Reed, CK
    Jensen, KLD
    Finkelstein, JN
    Keng, PC
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 24 (06) : 703 - 710
  • [27] FMN2 is a novel regulator of the cyclin-dependent kinase inhibitor p21
    Yamada, Kayo
    Ono, Motoharu
    Bensaddek, Dalila
    Lamond, Angus I.
    Rocha, Sonia
    CELL CYCLE, 2013, 12 (15) : 2348 - 2354
  • [28] Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor
    M A Rego
    J A Harney
    M Mauro
    M Shen
    N G Howlett
    Oncogene, 2012, 31 : 366 - 375
  • [29] APP overexpression UP-regulates P21, A cyclin-dependent kinase inhibitor
    Nilsson, T
    Folkesson, R
    Winblad, B
    Benedikz, E
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S200 - S200
  • [30] The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis
    Monkawa, T
    Pippin, J
    Yo, Y
    Kopp, JB
    Alpers, CE
    Shankland, SJ
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2006, 102 (01): : E8 - E18